Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
Abstract Background Mild cognitive impairment (MCI) is a transitional state between normal ageing and dementia. Most MCI patients will progress to dementia within 5 years; therefore, early intervention for MCI is important for delaying the occurrence and progression of dementia. Yi Shen Fang (YSF) g...
Main Authors: | Zhongwei Sha, Zhenghao Zhao, Nana Li, Shuyun Xiao, Ou Li, Jie Zhang, Zhimin Li, Jian Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-023-03940-x |
Similar Items
-
Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial
by: Shengnan Yue, et al.
Published: (2019-08-01) -
The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study
by: Erik Hessen, et al.
Published: (2014-04-01) -
MCI, en dan? De toekomst van 'mild cognitive impairment'
by: Han F.A. Diesfeldt
Published: (2014-11-01) -
Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
by: Eric D. Anderson, et al.
Published: (2016-01-01) -
MACE for Diagnosis of Dementia and MCI: Examining Cut-Offs and Predictive Values
by: Andrew J. Larner
Published: (2019-05-01)